Entitäten Zur letzten Folie zurück RAD001-RADPAC A randomized, double blind, multi-center phase III study evaluating paclitaxel with and without RAD001 in patients with gastric carcinoma who have progressed after therapy with a fluoropyrimidine-containing regimen Beginn Ende offen Ansprechpartner: HOPE PIProf.
{}